Research location

Nagaoka

Japan

Published trials17
Site observations18
Linked trials published17
Page1 / 1
Advertisement

Research activity in Nagaoka

Japan

CureCurrent currently publishes aggregate city-level research activity for this location: 17 trials and 18 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Nagaoka

17 linked trials · page 1 of 1
A Study of Atezolizumab in Patients With Unresectable, Locally Advanced or Metastatic NSCLC (J-TAIL)NCT03645330 · 2018-08-15 · 1 site observation
COMPLETED
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid ArthritisNCT03025308 · 2017-02-28 · 1 site observation
COMPLETED
Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateNCT02889796 · 2016-08-30 · 1 site observation
COMPLETED
Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX TherapyNCT02886728 · 2016-08-08 · 1 site observation
COMPLETED
Abatacept Post-marketing Clinical Study in JapanNCT01758198 · 2013-04-11 · 1 site observation
COMPLETED
The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid ArthritisNCT01533714 · 2012-01-26 · 1 site observation
TERMINATED
Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) TherapyNCT01463059 · 2011-10-01 · 1 site observation
COMPLETED
Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With HypertensionNCT01353274 · 2011-05-01 · 2 site observations
COMPLETED
A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01202188 · 2010-09-01 · 1 site observation
COMPLETED
Special Investigation (Follow-up Survey of the Study of Adalimumab (D2E7) for Prevention of Joint Destruction in Patients With Rheumatoid Arthritis in Japan (M06-859 (NCT00870467))NCT01163292 · 2010-03-01 · 1 site observation
COMPLETED
Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00876694 · 2009-03-01 · 1 site observation
COMPLETED
Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00794157 · 2008-11-01 · 1 site observation
COMPLETED
Survey on PD Patients With Depressive SymptomsNCT00614575 · 2007-01-01 · 1 site observation
COMPLETED
Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary DiseaseNCT02177318 · 2005-04-01 · 1 site observation
COMPLETED
Special Survey Long-term Treatment With Tiotropium on COPDNCT00638183 · 2005-04-01 · 1 site observation
COMPLETED
Special Survey on Parkinson's Disease Patients Treated Long-term Use of PramipexoleNCT00615914 · 2004-02-01 · 1 site observation
COMPLETED
Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-DopaNCT00613301 · 2004-02-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.